Tradestie Institutional Equity Comparison Engine
MTVA vs IMMX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
IMMX Overall Edge
IMMX Captures Institutional Edge (2โ1 Pillars ยท 5โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Immix Biopharma, Inc. Common Stock (IMMX) driven by superior Growth & Margin, Momentum & Technical while MTVA counters with relative strength in Options & Structure. Fundamentally, MTVA trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus IMMX at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, MTVA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against IMMX sits in BREAKDOWN (30th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
MTVA N/M vs IMMX N/M Fwd P/E
Growth & Margin Winner
IMMX
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner
IMMX
1Y +32.2% vs +64.5% ยท 52W Pos 4% vs 28%
Options & Structure Winner
MTVA
UNCLASSIFIED (N/A IV) vs BREAKDOWN (30th %ile IV)
MTVA
NASDAQ
MetaVia Inc. Common Stock
Pharmaceutical Preparations
$1.01
-5.61% 1D
Market Cap
$7.2M
1M Return
-27.34%
1Y Return
+32.2%
Forward P/E
N/M
Unified AI Score
48.0 / 100
HOLD
Tech 40.0
Fund 60.0
Flow 50.0
Mom 64.0
IMMX
NASDAQ
Immix Biopharma, Inc. Common Stock
Pharmaceutical Preparations
$6.96
-1.14% 1D
Market Cap
$590.0M
1M Return
-16.65%
1Y Return
+64.54%
Forward P/E
N/M
Unified AI Score
50.6 / 100
HOLD
Tech 38.0
Fund 64.0
Flow 67.0
Mom 64.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
MTVA +32.2%
IMMX +64.54%
Spread: +32.34 pp (IMMX Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
MTVA TTM Op. Margin: 0.0%
IMMX TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MTVA vs IMMX. Trailing 12-month operating profitability (MTVA 0.0% vs IMMX 0.0%) and valuation multiples (MTVA N/M vs IMMX N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | MTVA | IMMX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $7.2M | $590.0M | Larger Scale | IMMX |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | +0.0% | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -175.7% | -27.0% | Higher ROE | IMMX |
| 52-Week Range Position Momentum | 4% ($1โ$13) | 28% ($4โ$15) | Stronger Trend | IMMX |
| Beta / 30D Volatility Risk Regime | 1.30ฮฒ ยท 166% Vol | 1.65ฮฒ ยท 76% Vol | Lower Realized Risk | IMMX |
| Unified Institutional Score Composite Signal | 48.0 / 100 (HOLD) | 50.6 / 100 (HOLD) | Higher Composite | IMMX |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full MTVA vs IMMX Buy Guide
MTVA
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
IMMX
BREAKDOWN
62d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
30th %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither MTVA nor IMMX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.